Omni Brain

PharmAmorin

i-eb0c1eace6c225e04e82c72aefcfb855-ilovessris.jpg The Onion shares news of a drug designed to alleviate distrust of drug manufacturers.

“Out of a test group of 180, 172 study participants reported a dramatic rise in their passion for pharmaceutical companies,” said Pfizer director of clinical research Suzanne Frost. “And 167 asked their doctors about a variety of prescription medications they had seen on TV.”

Frost said a small percentage of test subjects showed an interest in becoming lobbyists for one of the top five pharmaceutical companies, and several browsed eBay for drug-company apparel.

PharmAmorin, available in 100-, 200-, and 400-mg tablets, is classified as a critical-thinking inhibitor, a family of drugs that holds great promise for the estimated 20 million Americans who suffer from Free-Thinking Disorder.

Pfizer will also promote PharmAmorin in an aggressive, $34.6 million print and televised ad campaign.

One TV ad, set to debut during next Sunday’s 60 Minutes telecast, shows a woman relaxing in her living room and reading a newspaper headlined “Newest Drug Company Scandal Undermines Public Trust.” The camera zooms into the tangled neural matter of her brain, revealing a sticky black substance and a purplish gas. The narrator says, “She may show no symptoms, but in her brain, irrational fear and dislike of global pharmaceutical manufacturers is overwhelming her very peace of mind.” After a brief summary of PharmAmorin’s benefits, the commercial concludes with the woman flying a kite across a sunny green meadow, the Pfizer headquarters gleaming in the background.

It’ll soon be available over the counter.

Via The Trouble with Spikol.

Comments

  1. #1 Brian G
    December 20, 2007

    I prefer fukitol myself.

  2. #2 Brad
    December 21, 2007

    Sorry, where you can you get these?

    Glory.

  3. #3 Brian G
    December 21, 2007

    I prefer fukitol myself.

The site is currently under maintenance and will be back shortly. New comments have been disabled during this time, please check back soon.